Current Value of Holding

$169 Million

Shares

2.3 Million

% of Portfolio

0.14%

Average Buy Price

$43.5

Avg closing price
Price range

18 PRIMECAP Management Edwards Lifesciences Trades

PRIMECAP Management acquired 2.3 Million Edwards Lifesciences shares worth $169 Million. That's 0.14% of their equity portfolio (105th largest holding). The first Edwards Lifesciences trade was made in Q1 2013. Since then PRIMECAP Management bought shares six more times and sold shares on eleven occasions. The stake costed the investor $100 Million, netting the investor a gain of 69% so far.

Avg closing price
Price range
Increased shares by 12.5% (+256 Thousand shares) Q1 2025
Avg closing price $71.66
Price range $67.95 - $76.19
Increased shares by 14.5% (+259 Thousand shares) Q4 2024
Avg closing price $70.20
Price range $64.54 - $75.92
Sold 1.5% shares (-26.3 Thousand shares) Q3 2024
Avg closing price $72.89
Price range $59.70 - $93.78
Sold 4.7% shares (-90 Thousand shares) Q2 2024
Avg closing price $88.55
Price range $84.30 - $94.31
Sold 1.8% shares (-35 Thousand shares) Q4 2023
Avg closing price $69.58
Price range $61.71 - $77.76
Sold 1.5% shares (-30 Thousand shares) Q1 2023
Avg closing price $78.60
Price range $74.27 - $84.51
Sold 4.4% shares (-90.3 Thousand shares) Q4 2022
Avg closing price $77.07
Price range $68.54 - $87.44
Sold 2.8% shares (-59.2 Thousand shares) Q2 2022
Avg closing price $103.52
Price range $86.50 - $128.27
Sold 3.3% shares (-72.8 Thousand shares) Q1 2022
Avg closing price $112.18
Price range $101.96 - $128.34
Sold 3.7% shares (-84.1 Thousand shares) Q4 2021
Avg closing price $116.64
Price range $106.37 - $130.68
Sold 6.3% shares (-153 Thousand shares) Q3 2021
Avg closing price $114.14
Price range $102.91 - $122.75
Increased shares by 4.5% (+105 Thousand shares) Q1 2021
Avg closing price $84.54
Price range $78.68 - $90.67
Increased shares by 44.6% (+716 Thousand shares) Q1 2020
Avg closing price $72.12
Price range $52.41 - $81.00
Increased shares by 7.0% (+105 Thousand shares) Q1 2018
Avg closing price $43.43
Price range $37.19 - $47.45
Sold 4.8% shares (-76.2 Thousand shares) Q4 2017
Avg closing price $36.70
Price range $33.79 - $39.39
Sold 6.2% shares (-104 Thousand shares) Q3 2017
Avg closing price $38.14
Price range $36.29 - $39.86
Increased shares by 100.0% (+840 Thousand shares) Q4 2015
Avg closing price $25.97
Price range $24.05 - $27.52
New holding (+840 Thousand shares) Q1 2013
Avg closing price $14.66
Price range $13.11 - $15.76

News about Edwards Lifesciences Corp and PRIMECAP Management

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!